Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Lotus Eye Hospital & Institute's Revenue for the
three
months ended in Jun. 2026 was ₹170.6 Mil. Lotus Eye Hospital & Institute's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹12.1 Mil.
Hence, Lotus Eye Hospital & Institute's Receivables Turnover for the
three
months ended in Jun. 2026 was 14.12.
Lotus Eye Hospital & Institute (BOM:532998) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Lotus Eye Hospital & Institute Receivables Turnover Related Terms
Lotus Eye Hospital & Institute Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute Receivables Turnover Chart
BOM:532998 vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute (BOM:532998) has a Receivables Turnover of 14.12 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Lotus Eye Hospital & Institute and its competitors. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #52 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 7.9%.
Is Lotus Eye Hospital & Institute's Receivables Turnover too high?
Lotus Eye Hospital & Institute's current Receivables Turnover is 14.12. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. Lotus Eye Hospital & Institute's value of 14.12 is 76.9% above this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #52 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #52 out of 662 companies for Receivables Turnover. This places Lotus Eye Hospital & Institute in the top 8% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.98. Lotus Eye Hospital & Institute's value of 14.12 is 76.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current Receivables Turnover of 14.12 is 76.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Receivables Turnover is 14.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹98.32, compared to a current price of ₹110.85 — trading 12.7% above its estimated fair value. The current Receivables Turnover is 14.12 and 76.9% above the Healthcare Providers & Services industry median of 7.98. Lotus Eye Hospital & Institute's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Receivables Turnover is 14.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹110.85 is trading 12.7% above its estimated GF Value™ of ₹98.32.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
Receivables Turnover: 14.12
GF Value™: ₹98.32 vs. price of ₹110.85 (12.7% above fair value)
Industry Position: 76.9% above the Healthcare Providers & Services median (#52 of 662)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
72GF Score
Get the complete analysis for BOM:532998
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
